Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Innoviva To Buy The Rest Of Entasis For Enterprise Value Of $113m

May 26 2022

• By Joseph Haas and Ayisha Sharma

Deal Watch 2021 — • Source: Shutterstock

Related Content

Keeping Track: Provention Teplizumab, AZ Anifrolumab Headline Submissions; AZ Brilinta Gains Stroke Risk Reduction Claim

Nov 08 2020

Keeping Track: US FDA Approval Binge Includes Brexafemme, Wegovy, Ryplazim, Truseltiq, Lybalvi, Tembexa

Jun 04 2021

Deal Watch: AbbVie To Try Caraway’s Lysosomal Function Approach To Parkinson’s

Jun 10 2021

Entasis Anticipates First FDA Approval Of Pathogen-Specific Antibacterial

Oct 21 2021

Deal Watch: BMS Licenses Bispecific TCR Candidate From Immatics

Dec 17 2021

Finance Watch: Exscientia Launches Last IPO Of Q3, Brings US Total To 88

Oct 01 2021

Asia Deal Watch: Astellas Acquires Global Rights To KaliVir Oncolytic Virus Candidate

Dec 17 2020

AZ Spins Out Entasis To Tackle Resistant Infections

Jul 21 2015

Endo Buys Six Injectables Amid Shattering Decline In EBITDA Guidance

May 17 2022

Formycon Highlights Greater Focus On Biosimilars As Athos Deal Completes

May 12 2022

Zymeworks Rejects ‘Opportunistic’ Investor Takeover Bid

May 23 2022

Bayer Shuffles Atara’s CAR-Ts Out Of Its Cell Therapy Deck

May 20 2022

Almirall Views Vitiligo As Next Dermatology Opportunity

May 18 2022

AstraZeneca Buys Into COVID-19 Antibodies From Newly Launched RQ Bio

May 17 2022

Orphazyme’s Sorry Story Ends In Fire Sale

May 19 2022

Related Companies

Innoviva, Inc.

Entasis Therapeutics Holdings Inc.

AstraZeneca PLC

Roche Holding AG

KaliVir Immunotherapeutics, LLC

Astellas Pharma, Inc.

Alcon Inc.

KALA BIO, Inc.

Myrtelle Inc.

Rescue Hearing, Inc.

Pfizer Inc.

Harvard University

Evotec SE

Almirall SA

Cugene, Inc.

Aprea Therapeutics, Inc.

Atrin Pharmaceuticals

University of Pennsylvania

Emergent BioSolutions, Inc.

Chimerix, Inc.

Mirum Pharmaceuticals, Inc.

Satiogen Pharmaceuticals, Inc.

Myeloid Therapeutics, Inc.

Acuitas Therapeutics

Beckley Psytech Limited

Empatica Inc.

Procaps Group, S.A.

MannKind Corporation

Zealand Pharma A/S

Proteros Biostructures GmbH

Statera BioPharma, Inc.

Lay Sciences, Inc.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.